News About: Pharm. Industry
Korea’s pharmaceutical technology transfer fees top 2.5 trillion won in 22 years
The country saw a drug-related cumulative technology transfer fee of 2.5 trillion won ($2.3 billion) over the past 22 years since Hanmi Pharma exported its formulation technology of ceftriaxone to Switzerland based Ro...
KPMA launches 13-member provisional operation committee
The Korea Pharmaceutical Manufacturers Association has finally patched up its differences to seek a new path. The KPMA’s board of directors meeting passed reform measures to create a provisional council led by 13 memb...
Norlevo could be sold over the counter
Customers will be able to buy prescription medicine such as contraceptive Norlevo at pharmacies without a prescription. Meanwhile, they will need a prescription to get morning-after pills.
Under the arrangement pre...
Osteoporosis drug Fosamax Plus D price to be slashed
MSD Korea said Tuesday that it will reduce the price of its osteoporosis medication, Fosamax Plus D, by 30 percent from June 1.
As the prices of 6,506 different medicines, 47.1 percent of the total 13,841 drugs tha...
Jeil-Kirin renames itself Kyowa Hakko Kirin Korea
Jeil-Kirin Pharma plans to change its English corporate name to Kyowa Hakko Kirin Korea from June 1 in a bid to make tremendous strides across key scientific fields, including oncology, immunology and nephrology.
J...
Daewoong posts largest per-capita sale
Daewoong Pharmaceutical Co. was the nation's most monthly active drug maker during the first quarter, with its per-capita sale topping the list among 52 listed pharmaceutical firms, except Kolon Life Sciences and Hwai...
Chong Kun Dang loses in lawsuit
Chong Kun Dang Pharmaceutical lost in a rebate lawsuit the company filed against the Ministry of Health and Welfare, claiming a 20-percent slash in drug prices is unlawful.
On Friday, the Seoul Administrative Court...
Korean companies set to launch high-dose Gleevec pills
Several Korean drug makers are poised to release high-dose Gleevec tablets, according to Dasan Medichem, a local formulation company.
Dasan has worked together with the country's seven leading pharmaceutical compa...
Kombiglyze XR pills approved in Korea for treatment of type 2 diabetes in adults
Bristol-Myers Squibb (BMS) Korea announced Sunday that the Korea Food and Drug Administration approved Kombiglyze XR tablets 2.5/1000mg for the treatment of type 2 diabetes in adults, following its approval of the sam...
18 products posting over 10 billion won in first-quarter sales
Local drug makers generated 18 products surpassing 10 billion won by value during the first quarter of this year.
Yakup.com, a pharmaceutical information company, said yesterday that the top seller was Bacchus, a p...
